280 related articles for article (PubMed ID: 12721327)
1. Expression and molecular pharmacology of the mouse CRTH2 receptor.
Hata AN; Zent R; Breyer MD; Breyer RM
J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
Hata AN; Lybrand TP; Marnett LJ; Breyer RM
Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
4. Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.
Mathiesen JM; Ulven T; Martini L; Gerlach LO; Heinemann A; Kostenis E
Mol Pharmacol; 2005 Aug; 68(2):393-402. PubMed ID: 15870392
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
Chiba T; Ueki S; Ito W; Kato H; Takeda M; Kayaba H; Furue M; Chihara J
Int Arch Allergy Immunol; 2009; 149 Suppl 1():77-82. PubMed ID: 19494510
[TBL] [Abstract][Full Text] [Related]
6. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
13. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway.
Chiba T; Kanda A; Ueki S; Ito W; Kamada Y; Oyamada H; Saito N; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2006; 141(3):300-7. PubMed ID: 16940740
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.
Mathiesen JM; Christopoulos A; Ulven T; Royer JF; Campillo M; Heinemann A; Pardo L; Kostenis E
Mol Pharmacol; 2006 Apr; 69(4):1441-53. PubMed ID: 16418339
[TBL] [Abstract][Full Text] [Related]
18. Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2).
Boehme SA; Franz-Bacon K; Chen EP; Ly TW; Kawakami Y; Bacon KB
Int Immunol; 2009 Jun; 21(6):621-32. PubMed ID: 19346259
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
[TBL] [Abstract][Full Text] [Related]
20. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
Sugimoto H; Shichijo M; Okano M; Bacon KB
Eur J Pharmacol; 2005 Nov; 524(1-3):30-7. PubMed ID: 16256979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
